急性肾损伤的门诊透析:进展与困境
美国需透析的急性肾损伤(AKI)患者增多且死亡率改善,出院时高达30%仍需门诊透析。2017年立法逆转了禁止在终末期肾病(ESRD)机构为AKI透析的政策,改善了透析选择但结局影响不明。目前缺乏证据指导这一脆弱人群的管理,需更多数据报告与分析。
要点
- 需透析的AKI患者增多,出院时高达30%仍需门诊透析。
- 2017年立法允许在ESRD机构为AKI透析,但结局影响不确定。
- 缺乏证据指导AKI门诊透析管理,需借鉴USRDS模式数据报告。
核心结论
- 需透析的AKI门诊患者增多,政策变化改善透析选择但结局影响尚不明确。
- 目前缺乏证据基础指导这一脆弱人群的管理,需更多数据报告与分析。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 美国需透析的AKI患者显著增加,但死亡率近期改善。
- 出院时高达30%的AKI患者仍需门诊透析。
- 2017年立法逆转了禁止在ESRD机构为AKI透析的CMS政策。
临床怎么用
- AKI门诊透析可移至ESRD机构,但需识别促进肾恢复的最佳实践。
- 这些实践应与标准ESRD方案不同。
局限性
- 缺乏证据基础指导AKI门诊透析管理。
- 政策变化对患者结局的影响尚不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dialysis-requiring acute kidney injury (AKI) has increased markedly in the United States. At the same time, mortality rates have recently improved. As such, increasing numbers of patients with AKI are surviving to hospital discharge, including up to 30% who will continue to require outpatient dialysis. In recent years, policy changes have significantly affected the care of this high-risk population. Beginning in 2017, new legislation reversed a previous Centers for Medicare & Medicaid Services policy that prohibited dialysis for AKI at end-stage renal disease (ESRD) facilities. This has improved dialysis options for patients, but the impact on patient outcomes remains uncertain. Unfortunately, there is currently a lack of evidence basis to guide management of this vulnerable patient population. Moving forward, additional data reporting and analyses will be required, analogous to how the US Renal Data System has helped inform ESRD care. As the dialysis setting for patients with AKI shifts to the ESRD setting, it is incumbent on the nephrology community to identify best practices to promote kidney recovery, recognizing that these practices will differ from standard ESRD protocols.
引用
- Heung M. Outpatient Dialysis for Acute Kidney Injury: Progress and Pitfalls. Am J Kidney Dis. 2019. PMID: 31204193. doi:10.1053/j.ajkd.2019.03.431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。